AstraZeneca (AZN) Tops Q2 EPS by 93c, Beats on Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to AstraZeneca (AZN) Tops Q2 EPS by 93c, Beats on Revenue

AstraZeneca (AZN) Appoints Michel Demare as Incoming Board Chair

July 29, 2022 5:57 AM EDT

AstraZeneca (NASDAQ: AZN) today announced the appointment of Michel Demaré as the Chair-designate of the Board.

His appointment followed a robust succession planning process led by Philip Broadley in his capacity as senior independent Non-Executive Director.

As previously communicated, Leif Johansson, current Chair of the Board of AstraZeneca will be retiring at the conclusion of the Companys Annual General Meeting in April 2023. Michels... More